{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:29:49Z","timestamp":1771680589054,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.prrv.2020.08.004","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T11:55:32Z","timestamp":1597924532000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Bacille Calmette Gu\u00e9rin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects"],"prefix":"10.1016","volume":"36","author":[{"given":"Nora","family":"Fritschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2020.08.004_b0005","first-page":"1589","article-title":"Premi\u00e8res essay de vaccination antituberculeuse de l'enfent par le bacille Calmette-Gu\u00e9rin","volume":"49","author":"Weill-Hall\u00e9","year":"1925","journal-title":"Bulletin et m\u00e9moires de la soci\u00e9t\u00e9 m\u00e9dicale des h\u00f4pitaux de Paris"},{"issue":"7","key":"10.1016\/j.prrv.2020.08.004_b0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2105\/AJPH.18.7.843-b","article-title":"Bacillus Calemette-Gu\u00e9rin (B.C.G.). Animal experimentation and prophylactic immunization of children","volume":"18","author":"Petroff","year":"1928","journal-title":"Am J Public Health"},{"issue":"24","key":"10.1016\/j.prrv.2020.08.004_b0015","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1001\/jama.1928.02700240030008","article-title":"Intradermal vaccination by BCG virus","volume":"91","author":"Wallgren","year":"1928","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.prrv.2020.08.004_b0020","series-title":"Vaccines","article-title":"Tuberculosis vaccines","author":"Smith","year":"2008"},{"issue":"6","key":"10.1016\/j.prrv.2020.08.004_b0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.prrv.2020.08.004_b0030","unstructured":"Trial of BCG vaccines in south India for tuberculosis prevention: first report--Tuberculosis Prevention Trial. Bull World Health Organ. 1979;57(5):819-827."},{"issue":"17","key":"10.1016\/j.prrv.2020.08.004_b0035","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"issue":"9517","key":"10.1016\/j.prrv.2020.08.004_b0040","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2020.08.004_b0045","doi-asserted-by":"crossref","unstructured":"Abubakar I, Pimpin L, Ariti C, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis. Health Technol Assess. 2013;17(37):1-372, v-vi.","DOI":"10.3310\/hta17370"},{"issue":"1 Pt 1","key":"10.1016\/j.prrv.2020.08.004_b0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2020.08.004_b0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.prrv.2020.08.004_b0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(06)70412-1","article-title":"The role of BCG in prevention of leprosy: a meta-analysis","volume":"6","author":"Setia","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.prrv.2020.08.004_b0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/jiy207","article-title":"Does BCG vaccination protect against nontuberculous Mycobacterial infection? A systematic review and meta-analysis","volume":"218","author":"Zimmermann","year":"2018","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.prrv.2020.08.004_b0075","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cid\/ciy241","article-title":"Increase in childhood nontuberculous Mycobacterial infections after Bacille Calmette-Gu\u00e9rin coverage drop: a nationwide, population-based retrospective study, Finland, 1995\u20132016","volume":"67","author":"Kontturi","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.prrv.2020.08.004_b0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0962-8479(05)80028-0","article-title":"Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage","volume":"76","author":"Romanus","year":"1995","journal-title":"Tuber Lung Dis"},{"issue":"5","key":"10.1016\/j.prrv.2020.08.004_b0085","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0962-8479(94)90080-9","article-title":"Six years' experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex","volume":"75","author":"Trnka","year":"1994","journal-title":"Tuber Lung Dis"},{"issue":"12","key":"10.1016\/j.prrv.2020.08.004_b0090","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.prrv.2020.08.004_b0095","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.prrv.2020.08.004_b0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/trstmh\/trv021","article-title":"BCG-associated heterologous immunity, a historical perspective: intervention studies in animal models of infectious diseases","volume":"109","author":"Freyne","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.prrv.2020.08.004_b0105","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.cmi.2019.02.016","article-title":"The impact of vaccines on heterologous adaptive immunity","volume":"25","author":"Messina","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.prrv.2020.08.004_b0110","first-page":"1481","article-title":"Preventive vaccination against tuberculosis with BCG","volume":"24","author":"Calmette","year":"1931","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.prrv.2020.08.004_b0115","unstructured":"Naeslund C. Resultats Des Experiences de Vaccination Par le BCG Poursuivies Dans le Norrbotten (Su\u00e8de) (Septembre 1927 \u2010 D\u00e9cembre 1931). In: Vaccination Pr\u00e9ventive de la Tuberculose de l'homme et des animaux par le B C G Rapports et Documents Provenant Des Divers Pays (la France except\u00e9e) transmis \u00e0 l'Institut Pasteur en 1932. . Paris, France: Mason and Cie; 1932:274\u2013281."},{"issue":"9","key":"10.1016\/j.prrv.2020.08.004_b0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.prrv.2020.08.004_b0125","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.prrv.2020.08.004_b0130","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial","volume":"65","author":"Biering-Sorensen","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/INF.0000000000002198","article-title":"Two randomized trials of the effect of the Russian Strain of Bacillus Calmette-Guerin alone or with oral polio vaccine on neonatal mortality in infants weighing <2000 g in India","volume":"38","author":"Jayaraman","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/INF.0000000000002230","article-title":"BCG vaccination and all-cause neonatal mortality","volume":"38","author":"Curtis","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.prrv.2020.08.004_b0145","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.prrv.2020.08.004_b0150","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.prrv.2020.08.004_b0155","first-page":"2122","article-title":"Non-specific effects of BCG vaccination on morbidity among children in Greenland: a population-based cohort study","volume":"45","author":"Haahr","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.prrv.2020.08.004_b0160","first-page":"2131","article-title":"BCG has no beneficial non-specific effects on Greenland. An answer to the wrong question?","volume":"45","author":"Benn","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.prrv.2020.08.004_b0165","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2013-2218","article-title":"Acute lower respiratory infection among Bacille Calmette-Guerin (BCG)-vaccinated children","volume":"133","author":"Hollm-Delgado","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.prrv.2020.08.004_b0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/jpids\/piy029","article-title":"BCG vaccination at birth and rate of hospitalization for infection until 15 months of age in danish children: a randomized clinical multicenter trial","volume":"8","author":"Stensballe","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"10.1016\/j.prrv.2020.08.004_b0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/archdischild-2016-310760","article-title":"BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial","volume":"102","author":"Stensballe","year":"2017","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.prrv.2020.08.004_b0180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/pr.2016.142","article-title":"Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial","volume":"80","author":"Kjaergaard","year":"2016","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0185","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.prrv.2020.08.004_b0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.prrv.2020.08.004_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077334","article-title":"The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNgamma response in Bacille Calmette-Guerin (BCG)-immunized infants","volume":"8","author":"Zufferey","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: Role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"issue":"10236","key":"10.1016\/j.prrv.2020.08.004_b0205","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","volume":"395","author":"Curtis","year":"2020","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.prrv.2020.08.004_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037535","article-title":"A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guerin immunisation in children and adults","volume":"7","author":"Ritz","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prrv.2020.08.004_b0215","doi-asserted-by":"crossref","unstructured":"Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv. 2020:2020.2003.2024.20042937.","DOI":"10.1101\/2020.03.24.20042937"},{"key":"10.1016\/j.prrv.2020.08.004_b0220","doi-asserted-by":"crossref","unstructured":"Berg MK, Yu Q, Salvador CE, Melani I, Kitayama S. Mandated Bacillus Calmette-Gu\u00e9rin (BCG) vaccination predicts flattened curves for the spread of COVID-19. medRxiv. 2020:2020.2004.2005.20054163.","DOI":"10.1101\/2020.04.05.20054163"},{"key":"10.1016\/j.prrv.2020.08.004_b0225","article-title":"Stop playing with data: there is no sound evidence that Bacille Calmette-Gu\u00e9rin may avoid SARS-CoV-2 infection (for now)","volume":"91","author":"Ricc\u00f2","year":"2020","journal-title":"Acta bio-medica: Atenei Parmensis"},{"key":"10.1016\/j.prrv.2020.08.004_b0230","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.prrv.2020.08.004_b0235","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.20.0267","article-title":"Bacille Calmette-Gu\u00e9rin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed","author":"Schaaf","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"10.1016\/j.prrv.2020.08.004_b0240","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis"},{"issue":"30","key":"10.1016\/j.prrv.2020.08.004_b0245","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.vaccine.2013.03.059","article-title":"Non-specific effect of Bacille Calmette-Guerin vaccine on the immune response to routine immunisations","volume":"31","author":"Ritz","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0250","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"issue":"28","key":"10.1016\/j.prrv.2020.08.004_b0255","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.vaccine.2019.03.016","article-title":"The influence of neonatal Bacille Calmette-Guerin (BCG) immunisation on heterologous vaccine responses in infants","volume":"37","author":"Zimmermann","year":"2019","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.prrv.2020.08.004_b0260","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.vaccine.2017.02.048","article-title":"Bacille Calmette-Guerin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial","volume":"35","author":"Nissen","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.prrv.2020.08.004_b0265","first-page":"1","article-title":"BCG: a vaccine with multiple faces","author":"Yamazaki-Nakashimada","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0270","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/archdischild-2013-305655","article-title":"Does neonatal BCG vaccination prevent allergic disease in later life?","volume":"99","author":"Freyne","year":"2014","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.prrv.2020.08.004_b0275","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5694\/mja13.10107","article-title":"Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG?","volume":"199","author":"Gwee","year":"2013","journal-title":"Med J Aust"},{"issue":"38","key":"10.1016\/j.prrv.2020.08.004_b0280","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1016\/j.vaccine.2015.06.097","article-title":"Paediatric Tuberculosis Network European Trials g. Current status of Bacille Calmette Guerin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines","volume":"33","author":"Dierig","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.prrv.2020.08.004_b0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tube.2016.08.005","article-title":"The impact of Bacille Calmette-Gu\u00e9rin shortage on immunisation practice and policies in Europe - A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey","volume":"101","author":"Kontturi","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.prrv.2020.08.004_b0290","unstructured":"World Health Organization. Global Tuberculosis Report 2019. 2019."},{"issue":"47","key":"10.1016\/j.prrv.2020.08.004_b0295","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.vaccine.2008.08.061","article-title":"To BCG or not to BCG? Preventing travel-associated tuberculosis in children","volume":"26","author":"Ritz","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.prrv.2020.08.004_b0300","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tube.2009.03.002","article-title":"Mapping the global use of different BCG vaccine strains","volume":"89","author":"Ritz","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"issue":"13","key":"10.1016\/j.prrv.2020.08.004_b0305","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.prrv.2020.08.004_b0310","doi-asserted-by":"crossref","first-page":"15443","DOI":"10.1038\/srep15443","article-title":"Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations","volume":"5","author":"Abdallah","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0315","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG \u2014 different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/rccm.201104-0714OC","article-title":"The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial","volume":"185","author":"Ritz","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2020.08.004_b0325","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3389\/fimmu.2019.02307","article-title":"Bacille Calmette-Gu\u00e9rin vaccine strain modulates the ontogeny of both mycobacterial-specific and heterologous T cell immunity to vaccination in infants","volume":"10","author":"Kiravu","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.prrv.2020.08.004_b0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032567","article-title":"Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan","volume":"7","author":"Favorov","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.prrv.2020.08.004_b0335","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.prrv.2020.08.004_b0340","article-title":"Early vaccination with BCG-Denmark or BCG-Japan versus BCG-Russia to healthy newborns in Guinea-Bissau: a randomized controlled trial","author":"Schaltz-Buchholzer","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.prrv.2020.08.004_b0345","unstructured":"UNICEF Supply Division. Bacillus Calmette-Gu\u00e9rin Vaccine: Supply and Demand Update. 2019."},{"key":"10.1016\/j.prrv.2020.08.004_b0350","doi-asserted-by":"crossref","unstructured":"Harris RC, Dodd PJ, White RG. The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality. BMC Med. 2016;14(1):138-138.","DOI":"10.1186\/s12916-016-0685-4"},{"issue":"1","key":"10.1016\/j.prrv.2020.08.004_b0355","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S2214-109X(18)30474-1","article-title":"Global shortages of BCG vaccine and tuberculous meningitis in children","volume":"7","author":"du Preez","year":"2019","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.prrv.2020.08.004_b0360","unstructured":"World Health Organization. BCG vaccines: WHO position paper \u2013 February 2018. Weekly epidemiological record. 2018;No 8, 93,:73\u201396."},{"issue":"10","key":"10.1016\/j.prrv.2020.08.004_b0365","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027033","article-title":"Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis","volume":"9","author":"Mahasha","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.prrv.2020.08.004_b0370","unstructured":"Ahmad NA, Abd Hamid HA, Sahril N, Yusoff M, BM N, Aris T. Bacille Calmette-Guerin (BCG) revaccination: is it beneficial for tuberculosis control? Open access scientific reports 2013; https:\/\/www.omicsonline.org\/scientific-reports\/2161-1068-SR-656.pdf."},{"issue":"5","key":"10.1016\/j.prrv.2020.08.004_b0375","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0074-02762005000500002","article-title":"BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis\u2013review","volume":"100","author":"Ben\u00e9volo-de-Andrade","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"10.1016\/j.prrv.2020.08.004_b0380","first-page":"351","article-title":"Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin","volume":"107","author":"Barclay","year":"1973","journal-title":"Am Rev Respir Dis"},{"issue":"7788","key":"10.1016\/j.prrv.2020.08.004_b0385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.prrv.2020.08.004_b0390","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0395","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/mi.2017.67","article-title":"PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4(+) T cell transcriptomal molecular signatures","volume":"11","author":"Hoft","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.prrv.2020.08.004_b0400","unstructured":"World Halth Organization. WHO preferred product characteristics for new tuberculosis vaccines. 2018."},{"issue":"43","key":"10.1016\/j.prrv.2020.08.004_b0405","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"Knight","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.prrv.2020.08.004_b0410","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1080\/21645515.2016.1205769","article-title":"Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines","volume":"12","author":"Harris","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.prrv.2020.08.004_b0415","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2020.00316","article-title":"Vaccination against tuberculosis: revamping BCG by molecular genetics guided by immunology","volume":"11","author":"Kaufmann","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.prrv.2020.08.004_b0420","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1473-3099(19)30625-5","article-title":"The status of tuberculosis vaccine development","volume":"20","author":"Schrager","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"25","key":"10.1016\/j.prrv.2020.08.004_b0425","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01(E) vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2020.08.004_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2020.08.004_b0435","first-page":"CD02915","article-title":"MVA85A vaccine to enhance BCG for preventing tuberculosis","volume":"4","author":"Kashangura","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0440","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nm.4488","article-title":"A new vaccine for tuberculosis in rhesus macaques","volume":"24","author":"Carpenter","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0445","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.prrv.2020.08.004_b0450","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S2213-2600(19)30251-6","article-title":"Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial","volume":"7","author":"Tameris","year":"2019","journal-title":"Lancet Respiratory Med"},{"issue":"2","key":"10.1016\/j.prrv.2020.08.004_b0455","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin Vaccine Immunol"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054220301202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054220301202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:37:01Z","timestamp":1761507421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054220301202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":91,"alternative-id":["S1526054220301202"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2020.08.004","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacille Calmette Gu\u00e9rin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2020.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}